Risk and Reward in the Orphan Drug Industry
© 2019 Portfolio Management Research. All rights reserved. Thanks to a combination of scientific advances and economic incentives, the development of therapeutics to treat rare or orphan diseases has grown dramatically in recent years. With the advent of Food and Drug Administration–approved gene th...
| 主要な著者: | , |
|---|---|
| フォーマット: | 論文 |
| 言語: | English |
| 出版事項: |
Pageant Media US
2021
|
| オンライン･アクセス: | https://hdl.handle.net/1721.1/134802 |
Search Result 1
